BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15621281)

  • 1. Activity of some platinum(II/IV) complexes with O,O-n-butyl-and O,O-n-pentyl-ethylenediamine-N,N'-di-3-propanoate and halogeno ligands against HeLa and K562 cell lines and human PBMC.
    Kaluderović GN; Dinović VM; Juranić ZD; Stanojković TP; Sabo TJ
    J Inorg Biochem; 2005 Feb; 99(2):488-96. PubMed ID: 15621281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro antitumoral activity of novel O,O'-di-2-alkyl-(S,S)-ethylenediamine-N,N'-di-2-propanoate ligands and corresponding platinum(II/IV) complexes.
    Krajcinović BB; Kaluderović GN; Steinborn D; Schmidt H; Wagner C; Zizak Z; Juranić ZD; Trifunović SR; Sabo TJ
    J Inorg Biochem; 2008 Apr; 102(4):892-900. PubMed ID: 18226835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold(III) complexes with esters of cyclohexyl-functionalized ethylenediamine-N,N'-diacetate.
    Pantelić N; Zmejkovski BB; Trifunović-Macedoljan J; Savić A; Stanković D; Damjanović A; Juranić Z; Kaluđerović GN; Sabo TJ
    J Inorg Biochem; 2013 Nov; 128():146-53. PubMed ID: 23988849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic Acid.
    Zmejkovski BB; Pantelić N; Filipović L; Aranđelović S; Radulović S; Sabo TJ; Kaluđerović GN
    Anticancer Agents Med Chem; 2017; 17(8):1136-1143. PubMed ID: 27928952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
    Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
    J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific ligands and their complexes. Part VII. Synthesis, characterization and in vitro antitumoral activity of platinum(II) complexes with O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)pentanoic acid.
    Vujić JM; Kaluđerović GN; Milovanović M; Zmejkovski BB; Volarević V; Živić D; Đurđeviće P; Arsenijević N; Trifunović SR
    Eur J Med Chem; 2011 Sep; 46(9):4559-65. PubMed ID: 21840630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: synthesis, characterization and in vitro antitumoral activity against chronic lymphocytic leukemia (CLL) cells.
    Vujić JM; Cvijović M; Kaluderović GN; Milovanović M; Zmejkovski BB; Volarević V; Arsenijević N; Sabo TJ; Trifunović SR
    Eur J Med Chem; 2010 Sep; 45(9):3601-6. PubMed ID: 20570025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
    Starha P; Trávnícek Z; Popa I
    J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
    ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
    Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
    J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
    Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ivanov D; Doytchinova I
    Arch Pharm (Weinheim); 2011 Apr; 344(4):209-16. PubMed ID: 21469169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron(III) complexes of tripodal monophenolate ligands as models for non-heme catechol dioxygenase enzymes: correlation of dioxygenase activity with ligand stereoelectronic properties.
    Mayilmurugan R; Visvaganesan K; Suresh E; Palaniandavar M
    Inorg Chem; 2009 Sep; 48(18):8771-83. PubMed ID: 19694480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of platinum(IV) complexes with dipeptide and diimine. X-ray crystal structure and 195Pt NMR spectra.
    Watabe M; Fukuda H; Kitsukawa K; Nakajima H; Yukawa Y; Igarashi S; Fujii Y; Takayama T
    J Inorg Biochem; 2006 Oct; 100(10):1653-9. PubMed ID: 16857262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterisation of mixed ligand Pt(II) and Pt(IV) oxadiazoline complexes.
    Sarju J; Arbour J; Sayer J; Rohrmoser B; Scherer W; Wagner G
    Dalton Trans; 2008 Oct; (39):5302-12. PubMed ID: 18827937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum(II/IV) complexes containing ethylenediamine-N,N'-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells.
    Kaluđerović GN; Mijatović SA; Zmejkovski BB; Bulatović MZ; Gómez-Ruiz S; Mojić MK; Steinborn D; Miljković DM; Schmidt H; Stošić-Grujičić SD; Sabo TJ; Maksimović-Ivanić DD
    Metallomics; 2012 Aug; 4(9):979-87. PubMed ID: 22820831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effects of palladium (II) and platinum (II) complexes with O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl) pentanoic acid on human colon cancer cell lines.
    Volarevic V; Vujic JM; Milovanovic M; Kanjevac T; Volarevic A; Trifunovic SR; Arsenijevic N
    J BUON; 2013; 18(1):131-7. PubMed ID: 23613398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure, spectra and reactivity of iron(III) complexes of facially coordinating and sterically hindering 3N ligands as models for catechol dioxygenases.
    Sundaravel K; Dhanalakshmi T; Suresh E; Palaniandavar M
    Dalton Trans; 2008 Dec; (48):7012-25. PubMed ID: 19050788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.